Payment overview · 2025
General Payments
$108.59
1 reported records · 1 companies
Healthcare provider profile · identity verified
Amy Marie Warner
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · KENT, WA · NPI 1972032845
Verified facts
What the public records show
CMS Open Payments records show Amy Marie Warner received $108.59 in general payments during 2025 across 1 reported records.
Axsome Therapeutics, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $108.59 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $108.59 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $108.59 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 986 | 185 |
| Trazodone Hcl | Trazodone Hcl | 503 | 115 |
| Amlodipine Besylate | Amlodipine Besylate | 484 | 103 |
| Levothyroxine Sodium | Levothyroxine Sodium | 428 | 101 |
| Lisinopril | Lisinopril | 391 | 87 |
| Gabapentin | Gabapentin | 372 | 72 |
| Furosemide | Furosemide | 313 | 74 |
| Tamsulosin Hcl | Tamsulosin Hcl | 313 | 56 |
| Quetiapine Fumarate | Quetiapine Fumarate | 296 | 89 |
| Losartan Potassium | Losartan Potassium | 295 | 76 |
| Omeprazole | Omeprazole | 293 | 61 |
| Sertraline Hcl | Sertraline Hcl | 285 | 66 |
| Metformin Hcl | Metformin Hcl | 284 | 62 |
| Famotidine | Famotidine | 263 | 55 |
| Pantoprazole Sodium | Pantoprazole Sodium | 236 | 48 |
| Potassium Chloride | Potassium Chloride | 223 | 55 |
| Mirtazapine | Mirtazapine | 185 | 45 |
| Eliquis | Apixaban | 176 | 42 |
| Metoprolol Tartrate | Metoprolol Tartrate | 173 | 40 |
| Risperidone | Risperidone | 167 | 43 |
| Citalopram Hbr | Citalopram Hydrobromide | 166 | 36 |
| Duloxetine Hcl | Duloxetine Hcl | 166 | 34 |
| Divalproex Sodium | Divalproex Sodium | 165 | 32 |
| Metoprolol Succinate | Metoprolol Succinate | 149 | 34 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 145 | 31 |
| Hydrochlorothiazide | Hydrochlorothiazide | 140 | 29 |
| Carvedilol | Carvedilol | 133 | 37 |
| Donepezil Hcl | Donepezil Hcl | 127 | 32 |
| Finasteride | Finasteride | 122 | 23 |
| Baclofen | Baclofen | 118 | 23 |
| Escitalopram Oxalate | Escitalopram Oxalate | 117 | 23 |
| Buspirone Hcl | Buspirone Hcl | 110 | 24 |
| Olanzapine | Olanzapine | 110 | 29 |
| Metformin Hcl Er | Metformin Hcl | 107 | 23 |
| Clopidogrel | Clopidogrel Bisulfate | 106 | 26 |
| Simvastatin | Simvastatin | 103 | 23 |
| Levetiracetam | Levetiracetam | 95 | 20 |
| Montelukast Sodium | Montelukast Sodium | 95 | 20 |
| Xarelto | Rivaroxaban | 88 | 19 |
| Memantine Hcl | Memantine Hcl | 87 | 21 |
| Spironolactone | Spironolactone | 85 | 20 |
| Allopurinol | Allopurinol | 81 | 14 |
| Diclofenac Sodium | Diclofenac Sodium | 77 | 22 |
| Paroxetine Hcl | Paroxetine Hcl | 76 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 75 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 72 | 27 |
| Alendronate Sodium | Alendronate Sodium | 70 | 19 |
| Hydralazine Hcl | Hydralazine Hcl | 69 | 18 |
| Jardiance | Empagliflozin | 68 | 15 |
| Glipizide | Glipizide | 63 | suppressed |
| Lorazepam | Lorazepam | 63 | 32 |
| Nystatin | Nystatin | 60 | 24 |
| Pravastatin Sodium | Pravastatin Sodium | 57 | 14 |
| Latanoprost | Latanoprost | 54 | 12 |
| Atenolol | Atenolol | 52 | suppressed |
| Ezetimibe | Ezetimibe | 52 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 51 | 12 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 51 | 13 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 47 | 30 |
| Unifine Pentips | Pen Needle, Diabetic | 45 | 12 |
| Nyamyc | Nystatin | 44 | 21 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 44 | suppressed |
| Torsemide | Torsemide | 43 | 11 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 43 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 39 | suppressed |
| Januvia | Sitagliptin Phosphate | 39 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 38 | suppressed |
| Lamotrigine | Lamotrigine | 36 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 36 | 13 |
| Midodrine Hcl | Midodrine Hcl | 36 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 35 | suppressed |
| Ibuprofen | Ibuprofen | 35 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 34 | suppressed |
| Meloxicam | Meloxicam | 34 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 34 | 23 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 33 | suppressed |
| Bumetanide | Bumetanide | 32 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 32 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 31 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 31 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 31 | suppressed |
| Clotrimazole | Clotrimazole | 30 | suppressed |
| Paliperidone Er | Paliperidone | 30 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 30 | 15 |
| Lactulose | Lactulose | 29 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 29 | suppressed |
| Loperamide | Loperamide Hcl | 27 | 18 |
| Chlorthalidone | Chlorthalidone | 26 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 26 | suppressed |
| Ketoconazole | Ketoconazole | 24 | 11 |
| Naproxen | Naproxen | 24 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 24 | suppressed |
| Valsartan | Valsartan | 24 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 23 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 22 | suppressed |
| Dulera | Mometasone/Formoterol | 22 | suppressed |
| Entresto | Sacubitril/Valsartan | 22 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 22 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 22 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 22 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 20 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 20 | suppressed |
| Lovastatin | Lovastatin | 20 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 20 | suppressed |
| Trulicity | Dulaglutide | 20 | suppressed |
| Clonazepam | Clonazepam | 19 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 19 | suppressed |
| Methocarbamol | Methocarbamol | 19 | suppressed |
| Prednisone | Prednisone | 19 | suppressed |
| Sodium Chloride | Sodium Chloride Irrig Solution | 19 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 19 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 18 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 18 | suppressed |
| Pregabalin | Pregabalin | 18 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 17 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 17 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 17 | 12 |
| Lidocaine | Lidocaine | 17 | suppressed |
| Ramipril | Ramipril | 17 | suppressed |
| Timolol Maleate | Timolol Maleate | 17 | suppressed |
| Ciclopirox | Ciclopirox | 16 | suppressed |
| Ozempic | Semaglutide | 16 | suppressed |
| Bupropion Xl | Bupropion Hcl | 15 | suppressed |
| Carbamazepine | Carbamazepine | 15 | suppressed |
| Cephalexin | Cephalexin | 15 | suppressed |
| Clonidine | Clonidine | 15 | suppressed |
| Digoxin | Digoxin | 15 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 15 | suppressed |
| Aripiprazole | Aripiprazole | 14 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 14 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 14 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 14 | suppressed |
| Ondansetron Odt | Ondansetron | 14 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 14 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 13 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 13 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Mupirocin | Mupirocin | 13 | suppressed |
| Novolog Flexpen | Insulin Aspart | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Pulmicort Flexhaler | Budesonide | 13 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Alprazolam | Alprazolam | 12 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 12 | suppressed |
| Clozapine | Clozapine | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 12 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 11 | suppressed |
| Dutasteride | Dutasteride | 11 | suppressed |
| Enulose | Lactulose | 11 | suppressed |
| Glipizide Er | Glipizide | 11 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 11 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $108.59 · 1 records | Axsome Therapeutics, Inc. | Auvelity | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error